DocGo Inc.(DCGO)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,578 of 2,879 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
DCGO Stock Analysis & AI Quality Score
AI stock analysis and institutional research for DocGo Inc. (DCGO), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores DCGO at 24.6/100 on a 32-signal composite quality model, placing it at rank #2,578 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (4.5) and balance sheet strength (7.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 24.6/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), DocGo Inc. reports quarterly revenue of $75.6M, net income of $-14.8M, free cash flow of $-5.1M. Top institutional holders of DCGO by reported 13-F value include BlackRock,, VANGUARD CAPITAL MANAGEMENT, P.A.W. CAPITAL, based on the most recent SEC filings. DCGO trades on the Nasdaq exchange and files with the SEC under CIK 1822359. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DCGO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for DocGo Inc. directly from SEC EDGAR.
Revenue
Q1 2026
$75.6M
Net Income
Q1 2026
$-14.8M
Free Cash Flow
Q1 2026
$-5.1M
D/E Ratio
Q1 2026
0.00
Get alerted when DCGO's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for DocGo Inc. including:
Top Institutional Holders of DCGO
BlackRock, Inc.
$4.0M6,366,028 shVANGUARD CAPITAL MANAGEMENT LLC
$2.3M3,682,568 shP.A.W. CAPITAL CORP
$1.9M3,000,000 shKnott David M Jr
$1.7M2,670,850 shCITADEL ADVISORS LLC
$1.6M2,500,000 shGEODE CAPITAL MANAGEMENT, LLC
$1.5M2,410,069 shS Squared Technology, LLC
$1.3M2,055,271 shSTATE STREET CORP
$1.2M1,966,843 shRENAISSANCE TECHNOLOGIES LLC
$950.2K1,510,361 shMOORE CAPITAL MANAGEMENT, LP
$921.6K1,465,000 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $4.0M | 6,366,028 |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.3M | 3,682,568 |
| P.A.W. CAPITAL CORP | $1.9M | 3,000,000 |
| Knott David M Jr | $1.7M | 2,670,850 |
| CITADEL ADVISORS LLC | $1.6M | 2,500,000 |
| GEODE CAPITAL MANAGEMENT, LLC | $1.5M | 2,410,069 |
| S Squared Technology, LLC | $1.3M | 2,055,271 |
| STATE STREET CORP | $1.2M | 1,966,843 |
| RENAISSANCE TECHNOLOGIES LLC | $950.2K | 1,510,361 |
| MOORE CAPITAL MANAGEMENT, LP | $921.6K | 1,465,000 |
More Healthcare Companies
View all Healthcare →Put DCGO on your watchlist
Track score changes the day DocGo Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is DCGO a good stock to buy?
13F Pro's AI-powered analysis of DocGo Inc. (DCGO) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for DCGO are available on the DCGO stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own DCGO?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling DCGO. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of DocGo Inc.'s investment landscape.